A drug safety evaluation of apixaban for the treatment of atrial fibrillation, acute coronary syndrome, and percutaneous coronary intervention-Reference-Cited by-同舟云学术

A drug safety evaluation of apixaban for the treatment of atrial fibrillation, acute coronary syndrome, and percutaneous coronary intervention

Published:2019-10-08 Issue:12 Volume:18 Page:1119-1125
ISSN:1474-0338
Container-title:Expert Opinion on Drug Safety
language:en
Short-container-title:Expert Opinion on Drug Safety

Author:

Gumprecht Jakub¹²,Domek Magdalena¹²,Lip Gregory Y. H.¹²³

Affiliation:

1. Liverpool Centre for Cardiovascular Science, University of Liverpool and Liverpool Heart & Chest Hospital, Liverpool, UK

2. Department of Cardiology, Congenital Heart Diseases and Electrotherapy, Silesian Medical University, Silesian Centre for Heart Diseases, Zabrze, Poland

3. Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Aalborg University, Aalborg, Denmark

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14740338.2019.1676723

Reference49 articles.

1. Stroke prevention in atrial fibrillation: Past, present and future

2. Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060

3. Epidemiology of atrial fibrillation: European perspective

4. All-cause mortality in 272 186 patients hospitalized with incident atrial fibrillation 1995–2008: a Swedish nationwide long-term case–control study

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacokinetics, safety, and bioequivalence of apixaban tablets in healthy Chinese subjects under fasting and fed conditions;Int. Journal of Clinical Pharmacology and Therapeutics;2023-03-01

2. Direct oral anticoagulants for the treatment and prevention of venous thromboembolism in patients with cancer: current evidence;Clinical and Translational Oncology;2020-11-18

3. Compliance of Atrial Fibrillation Treatment with the Atrial Fibrillation Better Care (ABC) Pathway Improves the Clinical Outcomes in the Middle East Population: A Report from the Gulf Survey of Atrial Fibrillation Events (SAFE) Registry;Journal of Clinical Medicine;2020-04-29